The purpose of this study was to determine the effect of 5′-AMP-activated protein kinase (AMPK) on energy metabolism and myosin heavy chain (MyHC) isoform expression in growing pigs using chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) as a model. Four-weekold pigs were given daily injections of AICAR or 0.9% saline for 10 d. Treatment with AICAR increased (P < 0.05) AMPK activity in semitendinosus muscles (STM). Expression of skeletal muscle specific glucose transporter 4 (GLUT4) was also enhanced (P < 0.05) by AICAR treatment. Using real-time PCR, electrophoresis, and Western blot analyses, we confirmed that AICAR treatment caused a decrease (P < 0.05) in type IIa MyHC isoform mRNA and protein levels and a concomitant increase (P < 0.05) in type IIx MyHC containing fibers. Consistent with a MyHC isoform shift from IIa to IIx, muscles from pigs treated with AICAR had greater (P < 0.05) lactate dehydrogenase (LDH) activity. Moreover, muscle of treated pigs expressed greater (P < 0.05) message for LDH. Administration of AICAR, however, did not alter expression of PPAR-γ coactivator-1α, fatty acid translocase, citrate synthase, or the activity of cytochrome c oxidase. Overall, these results indicate that activation of AMPK by AICAR causes muscle to assume a faster-contracting, more glycolytic nature. These data are in direct contrast to documented effects in rodent models, but these effects may be dependent on the time of administration and the overall growth status of the animal.
ABSTRACT:
The purpose of this study was to determine the effect of 5′-AMP-activated protein kinase (AMPK) on energy metabolism and myosin heavy chain (MyHC) isoform expression in growing pigs using chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) as a model. Four-weekold pigs were given daily injections of AICAR or 0.9% saline for 10 d. Treatment with AICAR increased (P < 0.05) AMPK activity in semitendinosus muscles (STM). Expression of skeletal muscle specific glucose transporter 4 (GLUT4) was also enhanced (P < 0.05) by AICAR treatment. Using real-time PCR, electrophoresis, and Western blot analyses, we confirmed that AICAR treatment caused a decrease (P < 0.05) in type IIa MyHC isoform mRNA and protein levels and a concomitant increase (P < 0.05) in type IIx MyHC containing fibers. Consistent with a MyHC isoform shift from IIa to IIx, muscles from pigs treated with AICAR had greater (P < 0.05) lactate dehydrogenase (LDH) activity. Moreover, muscle of treated pigs expressed greater (P < 0.05) message for LDH. Administration of AICAR, however, did not alter expression of PPAR-γ coactivator-1α, fatty acid translocase, citrate synthase, or the activity of cytochrome c oxidase. Overall, these results indicate that activation of AMPK by AICAR causes muscle to assume a faster-contracting, more glycolytic nature. These data are in direct contrast to documented effects in rodent models, but these effects may be dependent on the time of administration and the overall growth status of the animal.
INTRODUCTION
Skeletal muscle is dynamic tissue capable of undergoing extreme biochemical and physical changes in response to a myriad of external stimuli. Four major myosin heavy chain (MyHC) isoforms (I, IIa, IIx, and IIb) are expressed in the skeletal muscle of postnatal pigs. Their presence in various muscle fibers allows for differences in speed of contraction, which is strongly associated with a corresponding type of energy metabolism. Type I fibers contract relatively slowly and contain greater mitochondria and predominately oxidative enzymes. Type IIb fibers contain correspondingly type IIb MyHC, are the fastest contracting adult muscle fibers, and have the ability to produce greater amounts of ATP in the absence of oxygen. Type IIa and IIx fiber are intermediate in respect to contractile speed and metabolism Staron, 1997, 2000) .
The enzyme AMP-activated protein kinase (AMPK) is a major energy sensor of myocytes (Hardie et al., 1998) . It can be stimulated by addition of an AMPanalog (5-aminoimidazole-4-carboxamide-1-β-Dribofuranoside; AICAR) or from increased contractile activity, both of which induce a fast-to-slow and glycolytic-to-oxidative fiber type transition in skeletal muscle (Green et al., 1992) . Consistent with a typical fast-to-slow fiber type shift, increases in glucose transporter 4 (GLUT4) abundance are evident in muscle treated with AICAR or forced to exercise, along with corresponding changes in mitochondrial enzyme activities, such as PPAR-γ coactivator-1α (PGC-1α) and citrate synthase. Conversely, decreases in glycolytic enzyme activities, especially lactate dehydrogenase (LDH) are readily detected (Hardie and Sakamoto, 2005) . The objective of this study was to treat piglets with the AMP-analog AICAR and determine its role in modifying the metabolic and phenotypic characteristics of skeletal muscle fibers during the early postnatal period, which is a critical period for muscle fiber type diversification.
MATERIALS AND METHODS
Animals for this study were maintained at the Purdue University Swine Research Unit; experimental procedures were approved by the Purdue University Animal Care and Use Committee.
Animals and AICAR Injection
Four-week-old male pigs (York-Landrace crossbred) randomly assigned to a control (n = 9, saline) or AICAR injection (n = 9) group were reared under standard conditions and fed ad libitum. Pigs were administered AICAR by intravenous injection (0.775 µL of 20 mM AICAR/kg of BW; 40 mg/kg of BW) via jugular catheter every day for 10 d. At d 1, 5, and 10, BW were recorded. For metabolic profiling and MyHC analysis, pigs from control (n = 3) and AICAR (n = 3) groups were killed after 10 d of treatment; semitendinosus muscles (STM) were removed, and red and white portions of the STM were isolated and frozen in liquid nitrogen.
RNA Isolation, cDNA Synthesis, and Real-time PCR
Total RNA from red and white STM was extracted using the single-step RNA isolation method (Chomczynski and Sacci, 1987) , with modifications. Isolated RNA was treated with 4 U of DNase (Ambion, Indianapolis, IN) in 2 µL of a 10× DNase buffer containing 100 mM Tris-HCl (pH 7.5), 25 mM MgCl 2 , 5 mM CaCl 2 , and 3 µL of nuclease-free water to eliminate genomic DNA contamination. After 30 min of incubation, 5 µL of DNase inactivation reagent (Ambion) was added to the reaction. Ribonucleic acid was loaded into 0.22-µm SpinX centrifuge tube filters (VWR International, West Chester, PA) and centrifuged at 10,000 × g for 1 min at room temperature. One microliter of purified RNA (0.8 µg/µL) was then diluted in TE (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) buffer (249 µL). Twenty-five microliters of diluted RNA, 75 µL of TE buffer, and 100 µL of Ribogreen (Molecular probes, Carlsbad, CA) reagent were combined in a 96-well microplate, and fluorescence signal was measured at 480 (excitation) and 520 (emission) nm by GENios Pro fluoremeter (Tecan, Durham, NC). Complementary DNA was made using the random primed cDNA synthesis method. Total RNA (0.5 µg) in 5 µL nuclease-free water was added to 0.5 µL of 100 ng/µL of random hexamers and 0.5 µL of 100 µM dNTP. Samples were denatured at 65°C for 5 min after which 1 µL of 10 mM dithiothreitol (DTT; Invitrogen, Carlsbad, CA), 0.5 µL of 5 U Moloney Murine Leukemia Virus reverse transcriptase (Invitrogen), 0.5 µL of 0.5 U SUPERase-In (Ambion), and 2 µL of 5× First Strand Buffer (Invitrogen) were added in a total volume of 10 µL. The cDNA mixture was incubated in the thermal cycler (Eppendorf, Westbury, NY) at 25°C for 10 min, 37°C for 50 min, 70°C for 10 min, and chilled to 4°C. Complementary DNA samples were then diluted to 10 µg/mL in nuclease-free water. Real time quantification was performed in duplicate 15-µL reactions containing 5 µL of cDNA and 10 µL of the genespecific master mix. The PCR master mix consisted 10 µM gene-specific primers and iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) containing 100 mM KCl, 40 mM Tris-HCl (pH 8.4), 0.4 mM of each dNTP, 50 U of iTaq DNA polymerase/mL, 6 mM MgCl 2, SYBR Green I 7.5 µL, 20 nM fluorescein stabilizers (Bio-Rad), and nuclease-free water. β-Actin was used for internal controls. Primer sequences for β-actin, GLUT4, LDH, PGC-1α, fatty acid translocase (FAT/CD36), citrate synthase, and MyHC isoforms (type I, IIa, IIx, and IIb) are shown in Table 1 .
Real time quantification was performed for 40 cycles using iCycler real-time PCR detection system (Bio-Rad). Amplified real-time PCR products were sequenced to validate primer specificity. Samples were amplified in separate tubes, and the increase in fluorescence was measured in real time. The first cycle in the log-linear region of amplification in which a significant increase in fluorescence was detected above background was designated the threshold cycle (Ct). Quantification standards were composed of aliquots of PCR products in 10-fold serial dilutions ranging from 10 9 to 10 1 molecules. Standards were used to calculate a regression of Ct on molecule copy number to determine a log value of starting abundance for each cDNA aliquot, amplified in duplicate, based on individual Ct.
SDS-Glycerol Gel Electrophoresis of MyHC
Red and white STM were powdered in liquid nitrogen and homogenized in RIPA buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 0.25% sodium deoxycholate, 1% NP-40, 1 mM Na 3 VO 4 , 1 mM NaF, 1 µg/mL of aprotinin, leupeptin, and pepstatin with phosphatase inhibitor cocktail 1 and 2 (Sigma, St. Louis, MO). Samples were sonicated on ice for 5 s and centrifuged for 10 min at 10,000 × g at 4°C. Concentration of the isolated protein was determined using a BCA Protein Assay kit (Pierce, Rockford, IL). Then, 30 µg of protein per sample was resolved by SDS-PAGE.
For MyHC isoform analysis, red and white STM were powdered in liquid nitrogen, and myosin was extracted with a high ionic strength buffer (pH 6.5) containing 0.3 M KCl, 0.1 M KH 2 PO 4 , 50 mM K 2 HPO 4 , 10 mM EDTA, and 50% glycerol. Samples were then centrifuged at 10,000 × g for 20 min at 4°C. Supernatants were diluted 1:1 (vol/vol) with glycerol. Samples were then suspended in Laemmli buffer (pH 6.8) containing 10% SDS, 10% β-mercaptoethanol, and 20% glycerol in 0.5 M Tris and boiled for 5 min. Myosin heavy chain isoforms were separated with SDS glycerol gel electrophoresis according to the method of Talmadge and Roy (1993) with modifications. Briefly, MyHC isoforms were separated onto 8% polyacrylamide gels. Stacking gels were composed of 30% glycerol, 4% acrylamide:N,Nmethylene-bis-acrylamide (50:1), 0.5 M Tris (pH 6.8), 4 mM EDTA, and 0.4% SDS. The resolving gel consisted of 30% glycerol, 8% acrylamide:N,N-methylene-bisacrylamide (50:1), 0.4 M Tris (pH 8.8), 0.1 M glycine, and 4% SDS. Equal amounts of protein (5 µg per lane) were then loaded onto gels set on a Mini-Protein II Dual Slab Cell electrophoretic system (Bio-Rad) and separated for 30 h at 70 V at 4°C. After migration, the gels were silver-stained, images were captured, and the relative amounts of different MyHC isoforms were quantified using KODAK 1D Image Analysis Software (Kodak, New Haven, CT).
Western Blotting
Separated proteins were transferred to polyvinylidene fluoride membranes, blocked, and immunoblotted with primary antibodies overnight at 4°C. Secondary antibodies conjugated with horseradish peroxidase (1:1,000) were applied for 1 h at room temperature. Protein bands were visualized using enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL) and quantified using the NIH image J program.
AMPK Activity
The AMP-activated protein kinase activity was measured using the incorporation of 32 P into a SAMS peptide (His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-LeuVal-Lys-Arg-Arg) as described previously (Davies et al., 1989) . Briefly, powdered STM were homogenized in Polytron homogenizer with lysis buffer. After centrifugation at 13,000 × g for 5 min at 4°C, 10 µL of supernatant was incubated for 10 min at 37°C in 40 mM HEPES, 0.2 mM SAMS peptide (GenScript, Piscataway, NJ), 0.2 mM AMP, 80 mM NaCl, 8% wt/vol glycerol, 0.8 mM EDTA, 0.8 mM DTT, 5 mM MgCl 2 , and 0.2 mM ATP + 2 µCi [ 32 P] ATP (PerkinElmer, Waltham, MA), pH 7.0. An aliquot was spotted on Whatman P81 paper. Filter papers were washed 3 times with 1% phosphoric acid for 10 min, and radioactivity was quantified by scintillation counting. Activity of AMPK was assessed by the incorporation of 32 P into the SAMS substrate peptide. Activity was expressed as the relative amount of phosphorylated (mM) peptide per minute per gram of muscle.
LDH and COX Assays
Activity of LDH was measured by using a colorimetric LDH assay kit (E-107, Biomedical Research Service Center, University at Buffalo; Lynch et al., 2009 ) according to the manufacturer's instructions. Cytochrome C oxidase (COX) activity was assayed using a kit (Sigma) and following the manufacturer's protocol.
Antibodies and Chemicals
Primary antibodies used for immunoblotting were anti-phospho-AMPK (Thr   172   ) , anti-AMPK, anti-phospho-acetyl-coA carboxylase (ACC; Ser 79 ), anti-ACC (Cell Signaling Technology, Beverly, MA); anti-GLUT4 (Biogenesis, Brentwood, NH); anti-MyHC I (A4.840, Hughes and Blau, 1992) , anti-MyHC IIa (6B8, Depreux et al., 2000) , anti-MyHC IIb (BF-F3, Schiaffino et al., 1989) ; anti-fast MyHC (MY-32, immunoreactive with MyHC IIa, IIx, and IIb, Sigma). The horseradish peroxidase-conjugated secondary antibodies were purchased from Jackson ImmunoResearch (West Grove, PA). The ECL reagents were obtained from Amersham (Arlington Heights, IL); AICAR was purchased from Toronto Research Chemicals (Toronto, Canada). All other chemicals were obtained from Sigma.
Statistical Analysis
Data are represented as the least squares mean ± SE and compared with Student's t-test. Statistical significance was established at P < 0.05.
RESULTS

BW
The control and AICAR groups grew rapidly during the 10-d period. No differences in BW and absolute BW gain were observed between control and AICAR pigs throughout the duration of the study (data not shown).
AICA-altered AMPK Activity, AMPK Phosphorylation, and ACC Activity in the Red and White STM In 10 d control pigs (n = 3), phosphorylation level of AMPK was 1.27-fold greater (P < 0.05) in white STM compared with red STM ( Figure 1A ). Administration of AICAR for 10 d increased (P < 0.05) AMPK phosphorylation in white STM ( Figure 1A ). Evaluation of the known AMPK phosphorylation target ACC revealed AICAR administration increased (P < 0.05) ACC phosphorylation 1.4-and 1.56-fold in the red and white STM, respectively ( Figure 1B) . In muscle of control pigs, activity of AMPK was 1.4-fold greater (P < 0.05) in white STM compared with red STM ( Figure  1C ). The AICAR-treated pigs, on the other hand, had increased (P < 0.05) AMPK activity in red and white STM by 1.28-and 1.34-fold, respectively ( Figure 1C ). There was no significant interaction between muscle and AICAR. Real-time PCR. Because MyHC type IIa and IIx cannot be separated using SDS-PAGE approaches, muscle samples were further analyzed using real-time PCR in an attempt to quantify differences in MyHC IIa and IIx expression (Figure 3 ). Consistent with the protein level analyzed by SDS-PAGE, the relative differences in type I ( Figure 3A ) and type II b ( Figure 3D ) MyHC mRNA expression across muscles was evident, yet no differences were observed between control and AICAR- . Blots were stripped and reprobed with anti-AMPK and anti-ACC, respectively. The activities of AMPK were measured by synthetic peptide (SAMS) and P 32 were analyzed (C). a-c Means with different letters differ (P < 0.05, n = 3 in each group). treated pigs. Transcript abundance of MyHC type IIa, however, was less (P < 0.05) in the white STM compared with the red STM of control pigs ( Figure 3B ). Treatment with AICAR decreased (P < 0.05) type IIa MyHC mRNA in the red and white STM compared with controls. Type IIx mRNA expression ( Figure 3C ), on the other hand, was increased (P < 0.05) by AICAR treatment across both muscles.
AICAR Administration Changes MyHC
Western Blot Analyses. Total MyHC as well as type I, IIa, and IIb MyHC isoforms in muscles of control and AICAR-treated pigs are shown in a representative Western blot analysis ( Figure 4A ). The relative abundance of each MyHC isoform paralleled results of expression data. The MyHC type I protein was relatively greater in red STM and less in white STM ( Figure 4B ), whereas MyHC type IIb was less in red STM and greater in white STM of control pigs ( Figure 4D ). Treatment with AICAR did not alter the relative content of type I and IIb MyHC ( Figure 4B and 4D) . Consistent with expression data, type IIa MyHC was decreased (P < 0.05) by AICAR administration in the red and white STM ( Figure 4C ). Type IIx MyHC unfortunately could not be analyzed due to the lack of a reliable type IIx MyHC antibody for use in pig muscle.
Muscle GLUT4 Expression Increases in AICAR-fed Pigs
Level of GLUT4 mRNA was greater (P < 0.05) in the red STM compared with the white STM of control pigs ( Figure 5A ). Administration of AICAR for 10 d did not change GLUT4 mRNA in red STM, but AICAR increased (P < 0.05) GLUT4 expression in the white STM ( Figure 5A ). Content of GLUT4 in control pigs was greater (P < 0.05) in the red STM compared with its white contemporary ( Figure 5B ). Administration of AICAR increased (P < 0.05) GLUT4 protein in the red and white STM by 1.3-and 1.4-fold, respectively ( Figure 5B ).
PGC-1α, FAT/CD3, and Citrate Synthase Expressions, and Activity of COX
The relative abundance of PGC-1α ( Figure 6A ), FAT/CD36 ( Figure 6B ), and citrate synthase ( Figure  6C ) transcripts was measured by real-time PCR. Expressions of PGC-1α, FAT/CD36, and citrate synthase were greater (P < 0.05) in the red STM compared with the white STM of control pigs. No changes were ob- served due to AICAR administration ( Figure 6 ). Cytochrome C oxidase activity, however, was greater (P < 0.05) in the red STM compared with the white STM (100 vs. 69%).
LDH mRNA Expression and Activity
In control pigs, LDH mRNA did not differ with muscle type. There was no effect of AICAR on LDH mRNA level in the red STM. However, in white STM, administration of AICAR dramatically increased (P < 0.01) LDH mRNA expression ( Figure 7A ). The pattern of LDH activity ( Figure 7B ) in red STM was similar to that of mRNA expression level. In the control group, LDH activity was greater (P < 0.05) in the white STM compared with the red STM ( Figure 7A ). Treatment with AICAR elevated (P < 0.05) LDH activity only in white STM ( Figure 7B ).
DISCUSSION
The purpose of this study was to evaluate the effect of chronic AICAR treatment on AMPK activity and muscle adaptation in rapidly growing pigs. To assess muscle adaptation, we evaluated MyHC isoform expression and protein content as well as changes in major metabolic enzymes. We show herein that daily injections of the AMP-analog AICAR for 10 d increased AMPK activity and forced a MyHC isoform transition in muscle indicative of a slow to fast transition. This structural adaptation corresponded with an increase in GLUT4 protein content and altered enzyme activity. Muscles treated with AICAR had greater activity of LDH, a key enzyme involved in anaerobic glycolysis, compared with control. These results provide novel evidence that activation of AMPK influences skeletal muscle adaptation in a much different manner in growing animals than in mature animals.
We found that basal AMPK activity in control pigs, measured by phosphorylation of AMPK α Thr172 and ACC Ser79 and SAMS assay, was greater in the white STM than in the red STM. There are 3 major heterotrimers (α2/β2/γ1, α2/β2/γ3, α1/β2/γ1) in skeletal muscle that respond differently to various stimuli and may act on different targets (Kemp et al., 2002) . Although we did not determine expression of different AMPK isoforms in these muscles, it is possible that the proportions of different heterotrimers vary with fiber type or muscle function and thereby respond differently to AICAR stimulation. Alternatively, the difference in AMPK activity between red and white muscles may simply reflect differences in metabolic demands of dif- Myosin heavy chain expression in pigs ferent fiber types. Activities of ATPase and tension costs increase from type I to IIa to IIx to IIb (Pette and Staron, 2000) . As a result, white muscle (type IIb rich) may have a greater AMPK activity than red STM (type I and IIa rich) to more rapidly or effectively regulate energetic processes, thereby conserving energy for ATPase activity and tension cost. Thus, AMPK activity could be regulated according to the energetic requirements of different muscle fiber types. This suggests an intimate relationship between AMPK activity and muscle function.
Consistent with the aforementioned effect of activated AMPK on muscle fiber type and energy metabolism is the fact that Rendement Napole pigs possess a mutation in the gamma 3 subunit of AMPK, the portion of the enzyme responsible AMP binding, which results in a gain-in-function mutation in these pigs. As a result, AMPK in Rendement Napole pigs is constitutively active, and as a result, these pigs have muscle that is more oxidative in nature and contains a greater proportion of type IIx fibers than pigs lacking this mutation (Park et al., 2009b) . Chronic AMPK activation induces greater oxidative muscle fiber types in adult animals. Bamford et al. (2003) and Putman et al. (2003) reported an increase in oxidative metabolism in fast muscles without significant changes in the speed of contraction, indicating speed of contraction and energy metabolism can be uncoupled. Furthermore, Suwa et al. (2003) reported that 14-d AICAR administration increased glycolytic and oxidative enzyme activities concomitant with muscle fiber type shift from IIb to IIx in EDL muscle, again contrary to the central dogma that energy metabolism and speed of contraction are closely associated. Of course, great care must be exercised when interpreting MyHC-based data because of the difficulties associated with precisely defining each adult MyHC isoform. Also, we cannot exclude the possibility that subtle shifts in muscle metabolism can be made without changing the MyHC.
In contrast to previous studies, we found chronic AICAR treatment increased glycolytic capacity. We overcame difficulties in MyHC fiber typing reported by others by combined use of real-time PCR, gel electrophoresis, and Western blot analyses. Muscle fiber typespecific mRNA and protein expression indicate a shift from type IIa to IIx fibers. Gene expression and activity of the glycolytic enzyme, LDH, was also greater in AICAR-treated pigs. Moreover, we found no differences in mRNA expression of genes involved in mitochondrial biogenesis (PGC-1α), fatty acid transport (FAT/ CD36), and oxidative metabolism (citrate synthase) between control and AICAR-treated pigs. Given that enzyme activity may be a better indicator of enzyme capacity than gene expression, we also evaluated activity of COX. The COX activity tended to be greater in the red STM of AICAR-treated pigs relative to control but was not significant. As expected, red STM, which contains more slow twitch-oxidative fiber types, had increased expression of PGC1α, FAT/CD36, and citrate synthase compared with white STM. However, AICARinduced AMPK activity had no effect on expression of these enzymes.
In rodent skeletal muscle, chronic AMPK activation by AICAR increases GLUT4 content (Holmes et al., 1999; Ojuka et al., 2000; Park et al., 2009a) . Our results further confirm fiber type-specific GLUT4 expression between red and white STM. Distribution of GLUT4 in red-oxidative vs. white-glycolytic muscles, on the other hand, is somewhat controversial. Steady state GLUT4 content is inherently greater in red muscle vs. white muscle in rodents: more type I or oxidative muscles contain more GLUT4 than type IIb or glycolytic muscles (Kern et al., 1990) . In agreement with this, our results with pigs showed that red STM contains more GLUT4 than white STM. However, contradicting results have Means with different letters differ (P < 0.05).
Myosin heavy chain expression in pigs been reported in muscles from other species. Van Dam et al. (2004) showed in equine muscle that IIb fibers have greater GLUT4 levels than type I and IIa fibers. In rat and human skeletal muscle, GLUT4 level is not consistently greater in type I than in type II (Borghouts et al., 2000) . Daugaard et al. (2000) reported that exercise training increases GLUT4 level, but little relationship was noted between GLUT4 content and fiber type. Although the precise role in which AMPK regulates muscle fiber type-specific GLUT4 expression is not known, GLUT4 may be more related to muscle activity than to MyHC isoform.
As mentioned earlier, previous studies indicated that AMPK activation can alter muscle fiber type in adult animals; however, we used rapidly growing 4-wk-old pigs. This period of postnatal growth is fascinating in muscle because fiber plasticity is vulnerable to various stimuli and therefore was particularly interesting to study using an AICAR-mediated intervention. To this end, we first analyzed the MyHC isoform transition in STM from control pigs: MyHC type I and IIb did not change for 10 d in 4-wk-old control pigs; however, MyHC IIa and IIx tended to decrease in red STM and increase in white STM (data not shown). This result indicates that fiber type diversification may still be occurring in skeletal muscle of 4-wk-old control pigs. Therefore, we cannot exclude the possibility that AICAR treatment differentially affects muscle adaptation during the early postnatal period. Chronic AMPK activation is reported to induce changes in fiber type composition from IIb to IIx in adult animals (Suwa et al., 2003) . However, in our study, AICAR induced an opposite shift, namely a shift in those characteristics indicative of a type IIa to IIx conversion. Because AICAR was administered to pigs experiencing rapid growth, protein synthesis could be a major source of energy utilization. Therefore, discrepancies in AMPK-induced MyHC isoform transitions could be associated with the efficiency of protein accretion, degradation rate, or both. Another possibility is that AMPK directly regulates transcription/translation of specific MyHC isoform expression.
In early postnatal periods of growth, LDH and other glycolytic enzyme abundance predominate in muscle (Lefaucheur and Vigneron, 1986) . Protein restriction studies have shown that muscle growth reduction occurs in a fiber type-dependent manner, specifically targeting the faster, contracting more glycolytic muscle cells first, even though all fibers are affected in a negative manner (Dwyer and Stickland, 1992) . As a result, nutrient restriction-mediated atrophy that occurs rapidly in fasttwitch fibers (Solomon et al., 1994) may simply alter the relative proportions of MyHC transcripts, which may be viewed erroneously as a fiber type transition. In contrast, the muscle of AICAR-treated pigs may have access to additional energy substrates, resulting from enhanced AMPK activity, that allow increased maturation or oxidative to glycolytic transformation, which is a hallmark of rapid growth and increased protein deposition.
In summary, chronic AICAR treatment for 10 d decreased MyHC IIa and increased IIx in the STM of rapidly growing pigs. Concomitant with structural changes, AICAR treatment also increased the activity of the glycolytic enzyme, LDH. Based on the mechanisms by which chronic AMPK activity enhances oxidative capacity, increased glycolytic potential by 10 d AICAR treatment is intriguing and merits intense investigation. Although our findings reveal a novel role of AMPK in regulating skeletal muscle adaptation of growing pigs, age-dependent roles of AMPK on various signal pathways must be defined. Given the documented role of AMPK in regulating protein turnover, further studies may be warranted for studying AMPK activation and its impact on the mammalian target of rapamycin signaling cascade. 
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